BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 747042)

  • 1. [Tissue extracts of malignant human lymphomas in the leukocyte migration test].
    Schwalbe P; Arndt D; Müller-Hermelink HK
    Acta Biol Med Ger; 1978; 37(7):1105-12. PubMed ID: 747042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Suspension cultures of human malignant lymphoma in the leukocyte migration test].
    Arndt D; Schwalbe P
    Acta Biol Med Ger; 1978; 37(7):1113-23. PubMed ID: 581818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
    Lee C; Chen S; Lin T
    Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
    Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
    Schmeisser G; Kademann J
    Arch Geschwulstforsch; 1980; 50(2):169-72. PubMed ID: 7436701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients].
    Novikov DK; Borisenko ID; Shein IA
    Vopr Onkol; 1978; 24(12):50-5. PubMed ID: 83731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte migration inhibition with spleen extracts and other antigens in patients with renal allografts.
    Dormont J; Sobel A; Galanaud P; Crevon MC; Colombani J
    Transplant Proc; 1972 Jun; 4(2):265-9. PubMed ID: 4113699
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic phenomena in guinea pigs injected with homologous ganglia extracts].
    Bachmann AE; Pedace EA; Sperperato AM; Conway de Macario E
    Medicina (B Aires); 1965; 25(6):353-9. PubMed ID: 15154230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Migration and chemotaxis of donor leukocytes modified by serum of psoriasis patients and psoriasis scale extracts].
    Schwartze G; Wozniak KD; Wohlrab W; Höfer HW
    Dermatol Monatsschr; 1984; 170(10):637-41. PubMed ID: 6510540
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay.
    Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS
    J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders.
    Griesser H; Feller A; Lennert K; Minden M; Mak TW
    J Clin Invest; 1986 Nov; 78(5):1179-84. PubMed ID: 3771790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of correlation between inhibitory or stimulatory influence of kidney antigens on in vitro leukocyte and lymphocyte migration in renal-transplanted patients.
    Skopińska-Rózewska E; Lukasik R
    Arch Immunol Ther Exp (Warsz); 1981; 29(4):499-504. PubMed ID: 7036935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect leukocyte migration inhibition in breast cancer and benign breast disease patients by mouse mammary tumor virus grown in feline kidney cells.
    McCoy JL; Tagliabue A; Ames RE; Teramoto YA; Cannon GB; Alford C; Herberman RB; Schlom J
    J Natl Cancer Inst; 1984 Mar; 72(3):569-76. PubMed ID: 6321840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abundant expression of chemokines in malignant and infective human lymphadenopathies.
    Tedla N; Palladinetti P; Wakefield D; Lloyd A
    Cytokine; 1999 Jul; 11(7):531-40. PubMed ID: 10419655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell migration inhibition in human lymphomas using lymph node and cell line antigens.
    Braun M; Sen L; Bachmann AE; Pavlovsky A
    Blood; 1972 Mar; 39(3):368-76. PubMed ID: 4501089
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
    Hashimoto Y; Sekiguchi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.